Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Arthur Cole

Premium

DNAnexus has hired Arthur Cole as general manager in charge of marketing, sales, and business development activities across the European market.

Cole joins DNAnexus from management consulting firm Debon Strategic Partners, where he was a managing partner providing strategic analysis, business planning, and interim management services to biotechnology and molecular diagnostics companies. Prior to that, he was executive vice president at Visible Genetics before the company was acquired by Bayer Diagnostics. He also held a number of senior leadership positions over a 13-year period at Pharmacia Biotech.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.